As mentioned above, SLC39A10, a downstream target of c-Myc, in turn, also upregulated c-Myc expression, thereby forming a vicious feedback loop to promote the malignant progression of gastric cancer, implying that inhibition of c-Myc may attenuate the tumor-promoting effect of SLC39A10. Here, MYC is linked to neoplasm.